Analysis of the incidence of dermatomycosis in Azerbaijani Republic during 2000-2016
- Authors: Ahmedova SD1
-
Affiliations:
- Azerbaijan Medical University
- Issue: Vol 99, No 2 (2018)
- Pages: 296-300
- Section: Social hygiene and healthcare management
- URL: https://journal-vniispk.ru/kazanmedj/article/view/8423
- DOI: https://doi.org/10.17816/KMJ2018-296
- ID: 8423
Cite item
Full Text
Abstract
Aim. To conduct epidemiological analysis of the incidence of dermatomycosis (superficial mycoses of skin and its appendages) in the Republic of Azerbaijan during 2000-2016, as well as clinical epidemiological monitoring during 2011-2016.
Methods. Analysis of incidence of visits was performed in the Republican dermato-venerologic clinic, children's republican dermato-venerologic dispansary №3, city dermato-venerologic dispansary №1 of the Republic of Azerbaijan according to the forms of state statistical observation №9 («Information about predominantly sexually transmitted diseases, fungal skin infections and scabies») approved by the decree of Azerbaijan State Statistical Commission No. 72/5 issued on 04.12.2000. Clinical analysis of dermatomycosis incidence during 2011-2016 was performed based on the results of laboratory (microscopic) verification of mycelium of the fungus.
Results. During 2000-2016 in the Republic of Azerbaijan steady increase of the incidence of superficial mycoses of skin and its appendages was observed. In 2000 the incidence was 2783. In 2016, 12 630 cases were recorded, which is the peak value and is 4.5 times higher than in 2000. Clinical analysis of incidence of superficial mycoses of skin and its appendages in 2011-2016 demonstrated that the diagnosis of pityriasis versicolor (keratomycosis) took the leading place (33.5%). The second place in the prevalence was taken by smooth skin mycoses (32.7%), the third place - by candidiasis (skin and visible mucous membranes - 17.1%), the fourth place - by onychomycosis (14.5%), and the last place - by mycosis of the scalp and face (2.2%). Young population (10-20 years) is susceptible to keratomycosis, and adult population (30-50 years) - to smooth skin mycosis. We suggest that it is related to climate-geographic features, increased insolation, and as a result - to sweating and to disordered lipid-alkaline protective skin barrier. To confirm our hypothesis further investigation is necessary.
Conclusion. Incidence of superficial mycoses of skin and its appendages, increased by 4.5 times was revealed; the leading position in prevalence is taken by pityriasis versicolor, the second - by smooth skin mycoses and the third - by skin and visible mucous membranes candidiasis.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
S D Ahmedova
Azerbaijan Medical University
Author for correspondence.
Email: nauchnayastatya@yandex.ru
Baku, Azerbaijan
References
- Burova S.A. Features of management of fungal infections of the skin and its appendages in the risk groups. Klinicheskaya dermatologiya i venerologiya. 2014; (1): 47–51. (In Russ.)
- Goryachkina M.V., Belousova T.A., Potekaev N.N. Algorithm for local treatment of superficial skin mycoses. Klinicheskaya dermatologiya i venerologiya. 2012; (5): 42–47. (In Russ.)
- Kruglova L.S., Ponich E.S., Babushkin A.M. Evaluation of the effectiveness of the sertaconazole cream in patients with tinea pedis. Klinicheskaya dermatologiya i venerologiya. 2016; (6): 66–73. (In Russ.)
- Sergeev A.Yu., Sergeev Yu.V. Gribkovye infektsii. (Fungal infections.) Moscow: Binom. 2008; 480 p. (In Russ.)
- Sokolova T.V., Malyarchuk A.P., Malyarchuk T.A. Clinical and epidemiologic monitoring of superficial mycoses in Russia and improvement of the treatment. RMZh. 2011; (21): 1327–1332. (In Russ.)
- Havlickova A., Czaika V.A., Friedrich M. Epidemiological trends in skin mycoses worldwide. Mycoses. 2008; 51 (4): 2–15. doi: 10.1111/j.1439-0507.2008.01606.x.
- Plaum S., Verma A., Fleischer A.B.Jr. et al. Detection and relevance of naftifine hydrochloride in the stratum corneum up to four weeks following the last application of naftifine cream and gel, 2%. J. Drugs Dermatol. 2013; 12 (9): 1004–1008. PMID: 24002147.
Supplementary files
